Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2016 | BG Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2015 | CI |
2016 | BG Medicine Announces Board Changes | CI |
Sales 2014 | 2.79M 223M | Sales 2015 | 1.57M 125M | Capitalization | 4.06M 324M |
---|---|---|---|---|---|
Net income 2014 | -8M -639M | Net income 2015 | -5M -399M | EV / Sales 2014 | 5.28 x |
Net cash position 2014 | 1.16M 92.89M | Net cash position 2015 | 1.52M 122M | EV / Sales 2015 | 1.62 x |
P/E ratio 2014 |
-1.87
x | P/E ratio 2015 |
-0.5
x | Employees | 5 |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Hall
DFI | Director of Finance/CFO | 73 | 02/12/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Wilcox
CHM | Chairman | 69 | 11/05/15 |
Jeffrey R. Luber
BRD | Director/Board Member | 57 | 03/02/16 |
James O'Connor
BRD | Director/Board Member | 67 | 16/11/15 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 11 | |
-27.79% | 1.48B | |
-18.38% | 57.39M |
- Stock Market
- Equities
- BGMD Stock